[
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88301"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88301",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A fusion protein containing angiopoietin-2 (Ang2) and vascular endothelial growth factor (VEGF) derived peptides covalently attached, via a proprietary diketone linker, to a proprietary humanized catalytic aldolase monoclonal antibody, with potential antiangiogenic and antineoplastic activities. The Ang2/VEGF peptide moieties of Ang2/VEGF-binding peptides-antibody fusion protein CVX-241 bind to Ang2 and VEGF receptors, which may inhibit tumor angiogenesis and tumor cell proliferation. The proprietary humanized catalytic IgG1 monoclonal aldolase antibody contains reactive lysine residues in its binding sites, which react covalently with compounds having a diketone function; the Ang2 and VEGFR peptide moieties are then covalently attached to the diketone linkers via a proprietary spacer. Both VEGF and Ang2 are upregulated in a variety of cancer cell types and play a crucial role in angiogenesis. This agent possesses an enhanced half-life compared to the naked peptides."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C198860"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C198860"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C198860",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C198860",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88302"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Infigratinib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88302",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic activities. Infigratinib selectively binds to and inhibits the activities of FGFRs, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. FGFRs are a family of receptor tyrosine kinases which may be upregulated in various tumor cell types and may be involved in tumor cell differentiation and proliferation, tumor angiogenesis, and tumor cell survival."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C155727",
      "http://purl.obolibrary.org/obo/NCIT_C1742"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C155727",
      "http://purl.obolibrary.org/obo/NCIT_C1742"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155727",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C164035",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C1742"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155727",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C164035",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C1742"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88303"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Pexidartinib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88303",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A small-molecule receptor tyrosine kinase (RTK) inhibitor of proto-oncogene receptor tyrosine kinase (KIT), colony-stimulating factor-1 receptor (CSF1R) and FMS-like tyrosine kinase 3 (FLT3), with antineoplastic activity. Upon oral administration, pexidartinib targets, binds to and inhibits phosphorylation of KIT, CSF1R and FLT3 harboring an internal tandem duplication (ITD) mutation. This results in the inhibition of tumor cell proliferation. FLT3, CSF1R and FLT3 are overexpressed or mutated in many cancer cell types and play major roles in tumor cell proliferation and metastasis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C1967"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C1967"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88304"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Tasisulam Sodium"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88304",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The sodium salt of an acyl-sulfonamide with potential antineoplastic activity. Selectively toxic towards tumor cells, tasisulam appears to induce tumor cell apoptosis by a mitochondrial-targeted mechanism involving the loss of mitochondrial membrane potential and induction of reactive oxygen species (ROS). In combination with an angiogenesis inhibitor, this agent may exhibit synergistic antiangiogenic activity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C177298",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C177298",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C177298",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C177298",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88305"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Quaternary Ammonium Polyethylenimine Nanoparticles"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88305",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A crosslinked nanoparticle formulation containing quaternary ammonium polyethylenimine (QA-PEI) with potential antibacterial activity. The cationic polymer PEI kills bacteria by rupturing their cell membranes without the development of resistance.  Quaternary ammonium polyethylenimine nanoparticles can be incorporated into dental composite resins or silicon obturator prostheses and may prevent or delay bacterial growth."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C52588",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C52588",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C52588",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C52588",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88306"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "PARP1 Inhibitor PF-01367338"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88306",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C95421",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C95421",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C95421",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C95421",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88307"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Anti-EGFRvIII Immunotoxin MR1-1"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88307",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A recombinant immunotoxin consisting of single-chain variable domain fragment antibody directed against the tumor-specific antigen EGFRvIII (MR1scFv) fused to domains II and III of the Pseudomonas exotoxin (PE38KDEL), with potential antineoplastic activity. Upon administration, the antibody moiety of anti-EGFRvIII immunotoxin MR1-1 binds to EGFRvIII; upon internalization, the exotoxin portion inhibits protein synthesis, resulting in a reduction in tumor cell proliferation of EGFRvIII- expressing tumor cells. EGFRvIII, a type III in-frame deletion mutation of the epidermal growth factor receptor (EGFR) gene, is expressed by a variety of cancers, including glioblastoma multiforme, non-small lung carcinoma, and breast carcinoma. Compared to intact IgG antibodies, single-chain antibodies such as MR1scFv are smaller and may penetrate tumors better. Pseudomonas exotoxin PE38KDEL was modified to remove the natural cell binding domain."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C575"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C575"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C575",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C575",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88308"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Plozalizumab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88308",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A humanized monoclonal antibody directed against the human chemokine receptor 2 (CCR2), with potential antiangiogenic, immunomodulating, antimetastatic, and antineoplastic activities. Plozalizumab binds to CCR2 and prevents binding of the endothelium-derived CLL2 (monocyte chemoattractant protein-1 or MCP1) to its receptor CCR2, which may result in inhibition of CCR2 activation and so inhibition of angiogenesis, tumor cell migration, and tumor cell proliferation. In addition, this agent may reduce levels of C-reactive protein (CRP). The G-protein coupled receptor CCR2 is expressed on the surface of monocytes and macrophages, stimulates the migration and infiltration of these cell types, and plays an important role in inflammation, angiogenesis, and tumor cell migration and proliferation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88309"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Motixafortide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88309",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable inhibitor of CXC Chemokine Receptor 4 (CXCR4) with potential antineoplastic activity. CXCR4 antagonist BL-8040 selectively binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor 1 (SDF-1 or CXCL12) to the CXCR4 receptor and subsequent receptor activation, which may result in decreased tumor cell proliferation and migration. In addition, inhibition of CXCR4 may induce mobilization of hematopoietic cells from the bone marrow into blood. The G protein-coupled receptor CXCR4 plays an important role in chemotaxis and angiogenesis and is upregulated in several tumor cell types; SDF-1/CXCR4 interaction induces retention of hematopoietic cells in the bone marrow."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C107589",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C107589",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C107589",
      "http://purl.obolibrary.org/obo/NCIT_C63817",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C107589",
      "http://purl.obolibrary.org/obo/NCIT_C63817",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C8831"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Stage IV Hodgkin's Disease Lymphocyte Predominance Type"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C8831",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Stage IV adult Hodgkin disease means there is disseminated (multifocal) involvement of one or more extralymphatic organs, with or without associated lymph node involvement, or isolated extralymphatic organ involvement with distant (nonregional) nodal involvement. (from PDQ)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C8590",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C8590",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C8590",
      "http://purl.obolibrary.org/obo/NCIT_C27809",
      "http://purl.obolibrary.org/obo/NCIT_C7340",
      "http://purl.obolibrary.org/obo/NCIT_C45230",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C8590",
      "http://purl.obolibrary.org/obo/NCIT_C27809",
      "http://purl.obolibrary.org/obo/NCIT_C7340",
      "http://purl.obolibrary.org/obo/NCIT_C45230",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88310"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Allogeneic CMV/AdV-Specific Cytotoxic T Lymphocytes"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88310",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A population of allogeneic cytotoxic T lymphocytes (CTLs) specifically reactive to cytomegalovirus (CMV) and adenovirus (AdV) with potential antiviral activity. Allogeneic CMV/AdV-specific cytotoxic T lymphocytes are prepared by exposing donor-derived CTLs to a lethally irradiated Epstein-Barr virus-positive lymphoblastoid B cell line (EBV-LCL) that has been transduced with a clinical-grade adenoviral vector (Ad5f35CMVpp65) as a source of CMV and AdV antigens. Infusion of these CTLs into stem cell transplant recipients may prevent CMV and AdV viral disease."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C28676",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C28676",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28676",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28676",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88311"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Momelotinib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88311",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable small molecule inhibitor of wild-type (WT) Janus kinases 1 and 2 (JAK1/2), the JAK2 mutant form JAK2V617F, and activin A receptor type 1 (ACVR1; activin receptor like kinase 2; ALK2), with antineoplastic activity. Upon oral administration, momelotinib competes with JAK1/2 for ATP binding, which results in inhibition of JAK1/2 activation, inhibition of the JAK-STAT signaling pathway, and leads to the induction of apoptosis and a reduction of tumor cell proliferation in JAK1/2-expressing tumor cells. In addition, the inhibition of ALK2 prevents liver hepcidin formation, increases iron availability and increases red blood cell (RBC) production. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity and is often dysregulated in a variety of tumor cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C172200",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C172200",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C172200",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C172200",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88312"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Milciclib Maleate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88312",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The maleate salt form of milciclib, an orally bioavailable inhibitor of cyclin-dependent kinases (CDKs) and tropomyosin receptor kinase A (TRKA), with potential antineoplastic activity. CDK2/TRKA inhibitor PHA-848125 AC potently inhibits cyclin-dependent kinase 2 (CDK2) and exhibits activity against other CDKs including CDK1 and CDK4, in addition to TRKA. Inhibition of these kinases may result in cell cycle arrest and apoptosis of tumor cells that express these kinases. CDKs are serine/threonine kinases involved in regulation of the cell cycle and may be overexpressed in some cancer cell types. The neurotrophin receptor TRKA is mutated in a variety of cancer cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C155765",
      "http://purl.obolibrary.org/obo/NCIT_C192741",
      "http://purl.obolibrary.org/obo/NCIT_C200052"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C155765",
      "http://purl.obolibrary.org/obo/NCIT_C192741",
      "http://purl.obolibrary.org/obo/NCIT_C200052"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155765",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C192741",
      "http://purl.obolibrary.org/obo/NCIT_C2185",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C200052"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155765",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404",
      "http://purl.obolibrary.org/obo/NCIT_C192741",
      "http://purl.obolibrary.org/obo/NCIT_C2185",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C200052"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88313"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Polo-like Kinase 1 Inhibitor NMS-1286937"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88313",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor NMS-1286937 selectively inhibits PLK1, inducing selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis in normal cells. PLK1 inhibition may result in the inhibition of proliferation in PLK1-overexpressing tumor cells. PLK1 is a serine/threonine protein kinase crucial in the regulation of mitosis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C185140",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C185140",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C185140",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C185140",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88314"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Tepotinib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88314",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable inhibitor of MET tyrosine kinase with potential antineoplastic activity. Tepotinib selectively binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase. The receptor tyrosine kinase MET (also known as hepatocyte growth factor receptor or HGFR), is the product of the proto-oncogene c-Met and is overexpressed or mutated in many tumor cell types; this protein plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C143099"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C143099"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C143099",
      "http://purl.obolibrary.org/obo/NCIT_C164000",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C143099",
      "http://purl.obolibrary.org/obo/NCIT_C164000",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88315"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Vorsetzumab Mafodotin"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88315",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An antibody-drug conjugate (ADC) consisting of a humanized monoclonal antibody, directed against the extracellular domain of the human CD70 molecule, conjugated to the auristatin analogue monomethyl auristatin phenylalanine (MMAF), with potential antineoplastic activity. The anti-CD70 antibody moiety of vorsetuzumab mafodotin selectively binds to the extracellular domain of CD70 on tumor cell surfaces. Upon internalization, the MMAF moiety is released, binds to tubulin and inhibits its polymerization, which may result in G2/M phase arrest, tumor cell apoptosis and inhibition of cellular proliferation in tumor cells that overexpress CD70. CD70, the ligand for the costimulatory receptor CD27 and a member of the tumor necrosis factor (TNF) family, is found on the surfaces of various types of cancer cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C201550",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C201550",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201550",
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C200042",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C201550",
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C200042",
      "http://purl.obolibrary.org/obo/NCIT_C163758"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88316"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "CDC7 Kinase Inhibitor NMS-1116354"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88316",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor NMS-1116354 binds to and inhibits the activity of CDC7, which may result in the inhibition of DNA replication and mitosis, the induction of tumor cell apoptosis, and the inhibition of tumor cell proliferation in CDC7-overexpressing tumor cells. The serine-threonine kinase CDC7 initiates DNA replication by phosphorylating MCM2 (minichromosome maintenance complex component 2) at Ser40 and Ser53."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C61074"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C61074"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88317"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "HER2Bi-Armed Activated T Cells"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88317",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Activated T cells (ATC) that have been coated with bispecific antibodies (BiAb), with potential antineoplastic and immunomodulating activities. In vitro, T cells are activated through exposure to the anti-CD3 murine monoclonal antibody OKT3 and interleukin 2 for 14 days and then armed with anti-CD3 x anti-Her2 bispecific antibody (Her2Bi). Upon administration, HER2Bi-armed activated T cells attach to CD3-expressing T cells and HER2/neu-expressing tumor cells, selectively cross-linking T cells and tumor cells; this may result in the recruitment and activation of cytotoxic T lymphocyte (CTLs), CTL perforin-mediated tumor cell cytolysis, and the secretion of antitumor cytokines and chemokines."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C28676"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C28676"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C28676"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129826",
      "http://purl.obolibrary.org/obo/NCIT_C129820",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C142078",
      "http://purl.obolibrary.org/obo/NCIT_C28676"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88318"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Canerpaturev"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88318",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A non-engineered, naturally oncolytic, replication-competent spontaneous herpes simplex virus (HSV) type I mutant variant. Upon intratumoral injection, canerpaturev transfects, replicates in, and lyses rapidly dividing cells such as tumor cells. In addition, this agent may increase host immune responses that may kill non-infected tumor cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C717",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C717",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C717",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C717",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88319"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Iodine I-123 ADAM"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88319",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radiopharmaceutical containing the serotonin transporter (SERT) ligand ADAM [2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine] labeled with the radioisotope iodine I 123, with SERT-binding and radioisotope activities. Upon administration, iodine I 123 ADAM selectively binds to SERT-expressing cells; subsequently, SERT-expressing tissues may be visualized using single photon emission computed tomography (SPECT). SERT is a monamine transporter protein found in the membranes of neurons and platelets; in neurons it transports the neurotransmitter serotonin from synaptic spaces into presynaptic neurons, terminating serotonin's function."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C8832"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Recurrent Mixed Cellularity Classic Hodgkin Lymphoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C8832",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The reemergence of mixed cellularity classic Hodgkin lymphoma after a period of remission."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133592",
      "http://purl.obolibrary.org/obo/NCIT_C3517"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133592",
      "http://purl.obolibrary.org/obo/NCIT_C3517"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133592",
      "http://purl.obolibrary.org/obo/NCIT_C4937",
      "http://purl.obolibrary.org/obo/NCIT_C134157",
      "http://purl.obolibrary.org/obo/NCIT_C172133",
      "http://purl.obolibrary.org/obo/NCIT_C147861",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C27358",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C4813",
      "http://purl.obolibrary.org/obo/NCIT_C4798",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C3208",
      "http://purl.obolibrary.org/obo/NCIT_C9357",
      "http://purl.obolibrary.org/obo/NCIT_C7164",
      "http://purl.obolibrary.org/obo/NCIT_C3517"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133592",
      "http://purl.obolibrary.org/obo/NCIT_C4937",
      "http://purl.obolibrary.org/obo/NCIT_C134157",
      "http://purl.obolibrary.org/obo/NCIT_C172133",
      "http://purl.obolibrary.org/obo/NCIT_C147861",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C27358",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C4813",
      "http://purl.obolibrary.org/obo/NCIT_C4798",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C3208",
      "http://purl.obolibrary.org/obo/NCIT_C9357",
      "http://purl.obolibrary.org/obo/NCIT_C7164",
      "http://purl.obolibrary.org/obo/NCIT_C3517"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88320"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88320",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A split-virus, inactivated influenza A (H1N1) vaccine containing H1N1 immunizing antigen combined with the adjuvant AS03, with potential immunostimulating activity. Upon intramuscular vaccination, AS03-adjuvanted H1N1 influenza vaccine may elicit an immune response against the H1N1 virus and the production of anti-H1N1 antibodies. AS03 is a stabilized oil-in-water emulsion adjuvant containing DL-alpha-tocopherol, squalene and polysorbate 80 that non-specifically stimulates cell-mediated immune antigen responses."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C178427",
      "http://purl.obolibrary.org/obo/NCIT_C29694"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C178427",
      "http://purl.obolibrary.org/obo/NCIT_C29694"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C178427",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C29694"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C178427",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C29694"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88321"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fumagillin-Derived Polymer Conjugate XMT-1107"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88321",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A polymeric prodrug consisting of the fumagillol-derived small molecule XMT-1191 tethered to the hydrophilic, biodegradable70 kDa polymer poly[1-hydroxymethylethylene hydroxymethylformal] (PHF) with potential antiangiogenic and antineoplastic activities. Upon administration, fumagillin-derived polymer conjugate XMT-1107 releases XMT-1191, which may inhibit angiogenesis through the irreversible inhibition of the methionine aminopeptidase 2 (METAP2); although the exact mechanism of action has yet to be fully elucidated, this agent appears to induce cell cycle arrest in endothelial cells, inhibiting their proliferation and migration. Compared to an unconjugated fumagillin analog, XMT-1107 exhibits improved solubility and an extended half life due to its PHF backbone. METAP2, a member of the methionyl aminopeptidase family, binds two cobalt or manganese ions and protects the alpha subunit of eukaryotic initiation factor 2 (EIF2) from inhibitory phosphorylation by removing the amino-terminal methionine residue from nascent protein; this aminopeptidase may be overexpressed in a variety of tumor cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88322"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Docetaxel Formulation CKD-810"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88322",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An injectable formulation containing the taxane docetaxel, a semisynthetic analogue of paclitaxel, with antineoplastic activity. Docetaxel binds specifically to the beta-tubulin subunit of the microtubule, stabilizing tubulin and inhibiting microtubule disassembly, which results in cell-cycle arrest at the G2/M phase and cell death. This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and induces various mediators of the inflammatory response."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C67437",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C67437",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C67437",
      "http://purl.obolibrary.org/obo/NCIT_C25974",
      "http://purl.obolibrary.org/obo/NCIT_C273",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C67437",
      "http://purl.obolibrary.org/obo/NCIT_C25974",
      "http://purl.obolibrary.org/obo/NCIT_C273",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88323"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Burixafor"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88323",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable inhibitor of CXC chemokine receptor 4 (CXCR4) with receptor binding and hematopoietic stem cell-mobilization activities. Burixafor binds to the chemokine receptor CXCR4, thereby preventing the binding of stromal derived factor-1 (SDF-1 or CXCL12) to the CXCR4 receptor and subsequent receptor activation; this may induce the mobilization of hematopoietic stem and progenitor cells from the bone marrow into blood. CXCR4, a chemokine receptor belonging to the G protein-coupled receptor (GPCR) gene family, plays an important role in chemotaxis and angiogenesis and is upregulated in several tumor cell types; CXCL12/CXCR4 interaction induces retention of hematopoietic cells in the bone marrow."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C107589",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C107589",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C107589",
      "http://purl.obolibrary.org/obo/NCIT_C63817",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C107589",
      "http://purl.obolibrary.org/obo/NCIT_C63817",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88324"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Factor VIIa Inhibitor PCI-27483"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88324",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A reversible small-molecule inhibitor of activated factor VII (factor VIIa) with potential antineoplastic and antithrombotic activities.  FVII, a serine protease, becomes activated (FVIIa) upon binding with TF forming the FVIIa/TF complex, which induces intracellular signaling pathways by activating protease activated receptor 2 (PAR-2). Upon subcutaneous administration, factor VIIa inhibitor PCI-27483 selectively inhibits factor FVIIa in the VIIa/TF complex, which may prevent PAR-2 activation and PAR2-mediated signal transduction pathways, thereby inhibiting tumor cell proliferation, angiogenesis, and metastasis of TF-overexpressing tumor cells. In addition, this agent inhibits both the extrinsic and intrinsic coagulation cascades, preventing blood clot formation. TF, a blood protein overexpressed on the cell surface of a variety of tumor cell types, may correlate with poor prognosis; PAR-2 (also known as thrombin receptor-like 1) is a G protein-coupled receptor (GPCR) and a protease-activated receptor."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2189",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2189",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88325"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Anti-IL-1 alpha Monoclonal Antibody MABp1"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88325",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A human IgG1 monoclonal antibody directed against interleukin-1 alpha (IL1a) with potential A human IgG1 monoclonal antibody targeting the inflammatory cytokine interleukin-1 alpha (IL1a) with potential antineoplastic, anti-cachectic and anti-angiogenic activities. Anti-IL1a monoclonal antibody MABp1 targets and binds to IL1a and prevents IL1a activity. This prevents IL1a-mediated tumorigenesis and angiogenesis. In addition, MABp1 abrogates IL1a-mediated cachexia. IL1a, an inflammatory mediator expressed on monocytes, platelets and overexpressed by certain tumors, plays a key role in the promotion of tumor cell growth, metastasis and invasion. In addition, IL1a stimulates metabolic activity in the central nervous system."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C192094",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C192094",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C192094",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C192094",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88326"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Tipapkinogene Sovacivec"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88326",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine comprised of a modified, replication-defective, vaccinia virus Ankara (MVA) strain encoding the tumor-associated antigens (TAAs) human papillomavirus type 16 (HPV16) subtypes E6 and E7, and human interleukin-2 (IL-2), with potential immunostimulating and antineoplastic activities. Vaccination with tipapkinogene sovacivec stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing HPV16 E6 and E7, resulting in tumor cell lysis. Expression of IL-2 augments the specific CTL response against HPV16 E6- and E7-expressing tumor cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2313",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2313",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2313",
      "http://purl.obolibrary.org/obo/NCIT_C1572",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2313",
      "http://purl.obolibrary.org/obo/NCIT_C1572",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88327"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Bersanlimab"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88327",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A fully human IgG1 monoclonal antibody directed against intercellular adhesion molecule-1 (ICAM-1 or CD54), with potential antineoplastic activity. Bersanlimab selectively binds to the adhesion protein ICAM-1, which may result in antibody-dependent cellular cytotoxicity (ADCC), hyper-cross-linking-induced apoptosis, and a decrease in cellular proliferation of ICAM-1-expressing tumor cells. ICAM-1, normally expressed on leukocytes and endothelial cells, may be overexpressed in a variety of cancers."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C20401"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129822",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C20401",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88328"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Litronesib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88328",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An inhibitor of the kinesin-related motor protein Eg5 with potential antineoplastic activity. Litronesib selectively inhibits the activity of Eg5, which may result in mitotic disruption, apoptosis and consequently cell death in tumor cells that are actively dividing. The ATP-dependent Eg5 kinesin-related motor protein (also known as KIF11 or kinesin spindle protein-5) is a plus-end directed kinesin motor protein that plays an essential role during mitosis, particularly in the regulation of spindle dynamics, including assembly and maintenance."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C67440",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C67440",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C67440",
      "http://purl.obolibrary.org/obo/NCIT_C273",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C67440",
      "http://purl.obolibrary.org/obo/NCIT_C273",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88329"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Vistusertib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88329",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. Vistusertib inhibits the activity of mTOR, which may result in the induction of tumor cell apoptosis and a decrease in tumor cell proliferation. mTOR, a serine/threonine kinase that is upregulated in a variety of tumors, plays an important role downstream in the PI3K/Akt/mTOR signaling pathway."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C2201"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C2201"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C2201",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C2201",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C61074",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C8833"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Refractory Mixed Cellularity Classic Hodgkin Lymphoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C8833",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Mixed cellularity classic Hodgkin lymphoma that is resistant to treatment."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133736",
      "http://purl.obolibrary.org/obo/NCIT_C3517"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C133736",
      "http://purl.obolibrary.org/obo/NCIT_C3517"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133736",
      "http://purl.obolibrary.org/obo/NCIT_C7164",
      "http://purl.obolibrary.org/obo/NCIT_C9357",
      "http://purl.obolibrary.org/obo/NCIT_C3208",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C8836",
      "http://purl.obolibrary.org/obo/NCIT_C134154",
      "http://purl.obolibrary.org/obo/NCIT_C172280",
      "http://purl.obolibrary.org/obo/NCIT_C157686",
      "http://purl.obolibrary.org/obo/NCIT_C27357",
      "http://purl.obolibrary.org/obo/NCIT_C120186",
      "http://purl.obolibrary.org/obo/NCIT_C7628",
      "http://purl.obolibrary.org/obo/NCIT_C3517"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C133736",
      "http://purl.obolibrary.org/obo/NCIT_C7164",
      "http://purl.obolibrary.org/obo/NCIT_C9357",
      "http://purl.obolibrary.org/obo/NCIT_C3208",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C8836",
      "http://purl.obolibrary.org/obo/NCIT_C134154",
      "http://purl.obolibrary.org/obo/NCIT_C172280",
      "http://purl.obolibrary.org/obo/NCIT_C157686",
      "http://purl.obolibrary.org/obo/NCIT_C27357",
      "http://purl.obolibrary.org/obo/NCIT_C120186",
      "http://purl.obolibrary.org/obo/NCIT_C7628",
      "http://purl.obolibrary.org/obo/NCIT_C3517"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88330"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ad5-yCD/mutTK(SR39)rep-ADP"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88330",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A second generation, replication-competent adenovirus type 5 containing a yeast cytosine deaminase(yCD)/mutant sr39 herpes simplex virus thymidine kinase fusion (yCD/mutTKsr39) gene and the 11.6 kDa adenovirus death protein (ADP) gene with potential oncolytic activity. Upon intratumoral administration and transduction of Ad5-yCD/mutTK(SR39)rep-ADP into tumor cells and subsequent expression of cytosine deaminase and viral thymidine kinase, administered prodrugs 5-fluorocytosine (5-FC) and ganciclovir are converted into their respective metabolites 5-fluorouracil (5-FU) and ganciclovir-5-monophosphate (ganciclovir-MP); 5-FU is subsequently metabolized to cytotoxic active metabolites 5-fluoroxyuridine monophosphate (F-UMP) and 5-5-fluoro-2'-deoxyuridine-5'-O-monophosphate (F-dUMP); ganciclovir-TP subsequently is converted by mammalian thymidine kinase to cytotoxic ganciclovir-triphosphate (ganciclovir -TP). Tumor cells adjacent to tumor cells transduced with this agent may be killed through a 'bystander effect'. ADP may enhance spread and oncolytic activity of replication-competent adenoviruses. In addition to its oncolytic activity, Ad5-yCD/mutTK(SR39)rep-ADP may exhibit radiosensitizing activity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C204256",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C204256",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C204256",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C204256",
      "http://purl.obolibrary.org/obo/NCIT_C61199"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88331"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "TPH Inhibitor LX1606"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88331",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor prodrug with potential antiserotonergic activity. Upon administration, TPH inhibitor LX1606 is converted to its active metabolite LP-778902, which binds to and blocks the activity of TPH. This may result in a reduction in peripheral serotonin (5-HT) production and improvement of serotonin-mediated gastrointestinal effects such as severe diarrhea. TPH, the rate-limiting enzyme in serotonin biosynthesis, is overexpressed in carcinoid tumor cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": true,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C104171",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C104171",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C104171",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C104171",
      "http://purl.obolibrary.org/obo/NCIT_C28428"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88332"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Antibody-Drug Conjugate BAY79-4620"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88332",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C129823",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C129823",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129823",
      "http://purl.obolibrary.org/obo/NCIT_C129821",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1512",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88333"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Gamma-Secretase Inhibitor RO4929097"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88333",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An orally bioavailable, small-molecule gamma secretase (GS) inhibitor with potential antitumor activity. Gamma secretase inhibitor RO4929097 binds to GS and blocks activation of Notch receptors, which may inhibit tumor cell proliferation. The integral membrane protein GS is a multi-subunit protease complex that cleaves single-pass transmembrane proteins, such as Notch receptors, at residues within their transmembrane domains. Overexpression of the Notch signaling pathway has been correlated with increased tumor cell growth."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C200529",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C200529",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C200529",
      "http://purl.obolibrary.org/obo/NCIT_C783",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C200529",
      "http://purl.obolibrary.org/obo/NCIT_C783",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88334"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Non-Adjuvanted A(H1N1) Influenza Vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88334",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A monovalent vaccine containing hemagglutinin (HA) of influenza A (H1N1)-like virus with potential immunomodulating activity. Upon administration, non-adjuvanted A(H1N1) influenza vaccine may stimulate the immune system to mount an antibody response against H1N1."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C178427",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C178427",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C178427",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C178427",
      "http://purl.obolibrary.org/obo/NCIT_C96404",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88335"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Archexin"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88335",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A 20-mer antisense oligodeoxynucleotide (ODN) against the proto-oncogene Akt with potential antineoplastic activity. Akt-1 antisense oligonucleotide RX-0201 binds to Akt-1 mRNA, inhibiting translation of the transcript; suppression of Akt-1 expression may result in the inhibition of cellular proliferation and the induction of apoptosis in tumor cells that overexpress Akt-1. Akt-1 is a serine-threonine protein kinase that stimulates proliferation and inhibits apoptosis of tumor cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1291",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1291",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1291",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1291",
      "http://purl.obolibrary.org/obo/NCIT_C1962",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88336"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Holmium Ho 166 Poly(L-Lactic Acid) Microspheres"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88336",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Holmium Ho166 containing poly l-lactic acid (PLA) microspheres with potential antineoplastic actvity. Upon intra-arterial hepatic administration of holmium 166 microspheres, this agent is able to emit both beta particles direct killing cells and gamma photons for nuclear imaging. In addition, since holmium 166 is paramagnetic, this agent can be used for magnetic resonance imaging (MRI)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88337"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Smoothened Antagonist LDE225 Topical"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88337",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A topical formulation of the small-molecule Smoothened (Smo) antagonist LDE225 with potential antineoplastic activity. Upon topical application, smoothened antagonist LDE225 selectively binds to the Hedgehog (Hh)-ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and, so, the inhibition of tumor cells in which this pathway is abnormally activated. The Hh signaling pathway plays an important role in cellular growth, differentiation and repair. Inappropriate activation of Hh pathway signaling and uncontrolled cellular proliferation, as is observed in a variety of cancers, may be associated with mutations in the Hh-ligand cell surface receptor Smo."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C155725",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C155725",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155725",
      "http://purl.obolibrary.org/obo/NCIT_C188731",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C2189"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C155725",
      "http://purl.obolibrary.org/obo/NCIT_C188731",
      "http://purl.obolibrary.org/obo/NCIT_C163758",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C2189"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88338"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Vascular Disrupting Agent BNC105P"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88338",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A benzofuran-based vascular disrupting agent (VDA) prodrug with potential anti-vascular and antineoplastic activities. Upon administration vascular disrupting agent BNC105P, the disodium phosphate ester of BNC105, is rapidly converted to BNC105; in activated endothelial cells, BNC105 binds to tubulin and inhibits its polymerization, which may result in a blockage of mitotic spindle formation, cell cycle arrest, and disruption of the tumor vasculature. Hypoxic conditions ensue, depriving tumor cells of nutrients and resulting in tumor cell apoptosis. In addition to its VDA activity, this agent has a direct cytotoxic effect on tumor cells by inhibiting tubulin polymerization. BNC105 is not a substrate for the multidrug-resistance P-glycoprotein (Pgp) transporter."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C25974",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C25974",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C25974",
      "http://purl.obolibrary.org/obo/NCIT_C273",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C25974",
      "http://purl.obolibrary.org/obo/NCIT_C273",
      "http://purl.obolibrary.org/obo/NCIT_C186664",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88339"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Carbon C-14 Dacomitinib"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88339",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioconjugate consisting of an orally bioavailable small-molecule inhibitor of the epidermal growth factor receptor (erbB or HER) family of tyrosine kinases radiolabeled with carbon-14 with potential antineoplastic and beta-emitting radioisotope activity. PF-00299804 specifically and irreversibly binds to and inhibits human Her-1, Her-2, and Her-4, resulting in the proliferation inhibition and apoptosis of tumor cells that overexpress these receptors. The HER receptor family of tyrosine kinases, often overexpressed by a variety of tumor cell types, may contribute to tumor cell proliferation, differentiation, migration, and survival. PF-00299804 radiolabeled with carbon C-14 may be used as a radiotracer in pharmacological studies of PF-00299804 metabolism."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129819",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C2124"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C8834"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C8834",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma)."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C141224",
      "http://purl.obolibrary.org/obo/NCIT_C8517"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C141224",
      "http://purl.obolibrary.org/obo/NCIT_C8517"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C141224",
      "http://purl.obolibrary.org/obo/NCIT_C141141",
      "http://purl.obolibrary.org/obo/NCIT_C141139",
      "http://purl.obolibrary.org/obo/NCIT_C27268",
      "http://purl.obolibrary.org/obo/NCIT_C3208",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C9357",
      "http://purl.obolibrary.org/obo/NCIT_C3517",
      "http://purl.obolibrary.org/obo/NCIT_C7164",
      "http://purl.obolibrary.org/obo/NCIT_C8517",
      "http://purl.obolibrary.org/obo/NCIT_C8318"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C141224",
      "http://purl.obolibrary.org/obo/NCIT_C141141",
      "http://purl.obolibrary.org/obo/NCIT_C141139",
      "http://purl.obolibrary.org/obo/NCIT_C27268",
      "http://purl.obolibrary.org/obo/NCIT_C3208",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C9357",
      "http://purl.obolibrary.org/obo/NCIT_C3517",
      "http://purl.obolibrary.org/obo/NCIT_C7164",
      "http://purl.obolibrary.org/obo/NCIT_C8517",
      "http://purl.obolibrary.org/obo/NCIT_C8318"
    ],
    "hasDirectChildren": true,
    "numDescendants": 2,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 2,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88340"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Topical PVDF/Sirolimus"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88340",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A topical formulation consisting of a polyvinylidene fluoride (PVDF) polymer resin containing the macrolide sirolimus (rapamycin), produced by the organism Streptomyces hygroscopicus, with immunosuppressive activity. Upon application of topical PVDF/sirolimus, sirolimus migrates from the PVDF polymer resin into the skin. Once inside cells, sirolimus binds to the immunophilin FK binding protein-12 (FKBP-12) and forms a sirolimus:FKBP-12 complex. This complex binds to and inhibits the activity of the serine/threonine kinase mammalian target of rapamycin (mTOR), which may result in the suppression of cytokine-driven T-cell activation and proliferation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C574",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C574",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88341"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "3'-Aminomethyl Nicotine-P. aeruginosa r-Exoprotein A Conjugate Vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88341",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A hapten-carrier immunoconjugate composed of the hapten trans-3'-aminomethyl nicotine conjugated to a recombinant P. aeruginosa exoprotein A, rendered nontoxic through amino acid depletion, with potential immunostimulating activity. Upon vaccination with 3'-aminomethyl nicotine-P. aeruginosa r-exoprotein A conjugate vaccine, the immune system may produce anti-nicotine antibodies. Antibody-bound nicotine cannot pass the blood brain barrier (BBB) to activate brain nicotine receptors. Nicotine, a small organic molecule that is not immunogenic, must be haptenized and conjugated to a carrier protein, such as nontoxic recombinant P. aeruginosa exoprotein A, to induce an antibody response. Aluminium hydroxide may be used as an adjuvant for this vaccine."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1455",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1455",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1455",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1455",
      "http://purl.obolibrary.org/obo/NCIT_C923",
      "http://purl.obolibrary.org/obo/NCIT_C307",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88342"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "CpG Oligodeoxynucleotide GNKG168"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88342",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A synthetic, 21-mer, unmethylated CpG motif-based oligodeoxynucleotide (ODN), with immunostimulatory activity. CpG oligodeoxynucleotide GNKG168 binds to and activates Toll-like receptor 9 (TLR9) and is taken up into cells by endocytosis; once internalized, it may activate numerous signaling transduction pathways resulting in the release of multiple cytokines, such as immunoglobulins (Igs), interferons (IFNs), interleukins (ILs) and tumor necrosis factor (TNF). Through activation of TLR9, this ODN can directly stimulate B-lymphocytes, dendritic and natural killer (NK) cells, resulting in an increase in innate immunity and antibody-dependent cellular cytotoxicity (ADCC). In addition, through the release of IL-12 and IFN, this agent may induce a preferential shift to the T-helper 1(Th1) phenotype resulting in enhanced CD8+ T cell-mediated antitumor cytotoxicity."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2139",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2139",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2139",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2139",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88344"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fimaporfin A"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88344",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The A isomer of fimaporfin, a synthetic light-activated compound, with potential photosensitizing activity. Upon administration, fimaporfin A incorporates into the cell's endosome and lysosome membranes. Subsequently, cytotoxic agents are administered and accumulate in endosomal and lysosomal compartments; upon local activation by light, fimaporfin A produces reactive oxygen species (ROS), such as singlet oxygen, damaging endo/lysosomal membranes and accumulated cytotoxic agents are released into the tumor cell cytosol. This photochemical internalization (PCI) method can enhance the efficacy and selectivity of cytotoxic agents."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1420",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1420",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1420",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1420",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88345"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Onzigolide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88345",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A chimeric dopamine (DA)-somatostatin (SST) compound, with potential antineoplastic activity. Upon administration, onzigolide binds with high affinity to dopamine D2 receptor (D2R) and somatostatin receptor subtype 2 (SSTR2), and to a lesser extent to somatostatin receptor subtype 5 (SSTR5). This agent appears to exert its effect mainly by binding to D2R to activate the ERK1/2 and p38 MAPK pathways, thus inducing apoptosis and inhibiting cellular proliferation in non-functioning pituitary adenoma (NFPA) and neuroendocrine tumors. By binding to SSTR2, this agent may inhibit the secretion of growth hormone (GH) by the pituitary gland."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C129839",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C129839",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129839",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C129839",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88346"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "FAK Inhibitor GSK2256098"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88346",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A focal adhesion kinase-1 (FAK) inhibitor with potential antiangiogenic and antineoplastic activities. FAK inhibitor GSK2256098 inhibits FAK, which may prevent the integrin-mediated activation of several downstream signal transduction pathways, including ERK, JNK/MAPK and PI3K/Akt, thereby inhibiting tumor cell migration, proliferation and survival, and tumor angiogenesis. The tyrosine kinase FAK is normally activated by binding to integrins in the extracellular matrix (ECM) but may be upregulated and constitutively activated in various tumor cell types."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C199169",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C199169",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C199169",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C199169",
      "http://purl.obolibrary.org/obo/NCIT_C129825",
      "http://purl.obolibrary.org/obo/NCIT_C129824",
      "http://purl.obolibrary.org/obo/NCIT_C2189",
      "http://purl.obolibrary.org/obo/NCIT_C274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1742",
      "http://purl.obolibrary.org/obo/NCIT_C1967",
      "http://purl.obolibrary.org/obo/NCIT_C1404"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C88347"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Breast Cancer Pathologic Primary Tumor TNM Finding v7"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C88347",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A pathologic finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor.  The TNM pathologic and clinical primary tumor classifications of breast cancer are the same, regardless of whether they are based on pathologic and/or clinical criteria."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C88258",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C88258",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C88258",
      "http://purl.obolibrary.org/obo/NCIT_C88257",
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C88258",
      "http://purl.obolibrary.org/obo/NCIT_C88257",
      "http://purl.obolibrary.org/obo/NCIT_C48233",
      "http://purl.obolibrary.org/obo/NCIT_C48232",
      "http://purl.obolibrary.org/obo/NCIT_C3367",
      "http://purl.obolibrary.org/obo/NCIT_C7057"
    ],
    "hasDirectChildren": true,
    "numDescendants": 18,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 18,
    "isPreferredRoot": false
  }
]